2023

• Dahl, Alv A; Smeland, Knut Bjøro; Eikeland, Siri Asheim; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven; Fosså, Alexander. (2023) Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects. Journal of cancer survivorship
  Academic article
• Eikeland, Siri Asheim; Smeland, Knut Bjøro; Simensen, Victoria Charlotte; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven; Kiserud, Cecilie E.. (2023) Chronic fatigue in long-term survivors of Hodgkin’s lymphoma after contemporary risk-adapted treatment. Acta Oncologica
  Academic article
• Lia, Kjersti; R.K. Jørgensen, Rasmus; Wold, Bente Loftum; Fluge, Øystein; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven. (2023) Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study. Haematologica
  Academic article

2022

• Husby, Trine; Johansen, Håkon; Bogsrud, Trond; Hustad, Kari Vekseth; Evensen, Birte Veslemøy; Boellard, Ronald. (2022) A comparison of FDG PET/MR and PET/CT for staging, response assessment, and prognostic imaging biomarkers in lymphoma. Annals of Hematology
  Academic article
• Husby, Trine; Johansen, Håkon; Bogsrud, Trond; Hustad, Kari Vekseth; Evensen, Birte Veslemøy; Boellaard, Ronald. (2022) Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma. BMC Cancer
  Academic article
• Smeland, Knut Bjøro; Holte, Harald; Fagerli, Unn-Merete; Bersvendsen, Hanne Skjerven; Hjermstad, Marianne Jensen; Loge, Jon Håvard. (2022) Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life. Haematologica
  Academic article

2021

• Hernæs, Kjersti Helene; Smeland, Knut Bjøro; Fagerli, Unn-Merete; Kiserud, Cecilie E.. (2021) Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation. BMC Cancer
  Academic article
• Eikeland, Siri Asheim; Smeland, Knut Bjøro; Mols, Floortje; Fagerli, Unn-Merete; Bersvendsen, Hanne Skjerven; Kiserud, Cecilie E.. (2021) Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin’s lymphoma; symptom burden and quality of life. Acta Oncologica
  Academic article
• Åsberg, Arne; Løfblad, Lena; Felic, Amela; Aune, Marthe Wedø; Hov, Gunhild Garmo; Fagerli, Unn-Merete. (2021) Using blood calprotectin as a measure of blood neutrophils. Scandinavian Journal of Clinical and Laboratory Investigation
  Academic article

2020

• Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald. (2020) Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress. Bone Marrow Transplantation
  Academic article
• Leppä, Sirpa; Jørgensen, Judit; Tierens, Anne; Meriranta, Leo; Østlie, Ingunn; Brown, Peter de Nully. (2020) Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis. Blood Advances
  Academic article
• Kolstad, Arne; Illidge, Tim; Bolstad, Nils; Spetalen, Signe; Madsbu, Ulf Erik; Stokke, Caroline. (2020) Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma. Blood Advances
  Academic article

2019

• Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald; Smeland, Knut Bjøro. (2019) Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes. Acta Oncologica
  Academic article
• Fosså, Alexander; Smeland, Knut; Fagerli, Unn-Merete; Galleberg, Renate Berget; Bersvendsen, Hanne Skjerven; Holte, Harald. (2019) Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011–2016. Acta Oncologica
  Letter to the editor
• Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald. (2019) Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation. Bone Marrow Transplantation
  Academic article
• Simensen, Victoria C; Smeland, Knut Bjøro; Kiserud, Cecilie E.; Dahl, Alv A; Bersvendsen, Hanne Skjerven; Fluge, Øystein. (2019) Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma. Acta Oncologica
  Academic article

2018

• Hjort, Magnus Aasved; Hov, Håkon; Abdollahi, Pegah; Vandsemb, Esten; Fagerli, Unn-Merete; Lund, Bendik. (2018) Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration. Experimental hematology and oncology
  Academic article
• Smeland, Knut Bjøro; Loge, Jon Håvard; Aass, Hans Christian Dalsbotten; Aspelin, Trude; Bersvendsen, Hanne Skjerven; Bolstad, Nils. (2018) Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity. Bone Marrow Transplantation
  Academic article

2016

• Kolstad, Arne; Pedersen, Lone Bredo; Eskelund, Christian W.; Husby, Simon; Grønbæk, Kirsten; Jerkeman, Mats. (2016) Molecular monitoring after autologous stem cell transplantation and preemptive Rituximab treatment of molecular relapse; results from the Nordic mantle cell lymphoma studies (MCL2 and MCL3) with median follow-up of 8.5 years. Biology of Blood and Marrow Transplantation
  Academic article
• Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn-Merete; Falk, Ragnhild Sørum. (2016) A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma. British Journal of Haematology
  Academic article
• Kiserud, Cecilie E.; Fagerli, Unn-Merete; Smeland, Knut Bjøro; Fluge, Øystein; Bersvendsen, Hanne; Kvaløy, Stein Olav. (2016) Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. Acta Oncologica
  Academic article

2015

• Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein. (2015) Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway. Haematologica
  Academic article
• Aasheim, Lars Birger; Karlberg, Anna; Goa, Pål Erik; Håberg, Asta; Sørhaug, Sveinung; Fagerli, Unn-Merete. (2015) PET/MR brain imaging: evaluation of clinical UTE-based attenuation correction. European Journal of Nuclear Medicine and Molecular Imaging
  Academic article
• Aasheim, Lars Birger; Karlberg, Anna; Goa, Pål Erik; Håberg, Asta; Sørhaug, Sveinung; Fagerli, Unn-Merete. (2015) PET/MR - utfordringer og potensiale. Bestpractice Onkologi/Hematologi
  Article in business/trade/industry journal
• Pulczynski, Elisa J.; Kuittinen, Outi; Erlanson, Martin; Hagberg, Hans; Fosså, Alexander; Eriksson, Mikael. (2015) Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group. Haematologica
  Academic article

2014

• Kolstad, Arne; Laurell, Anna; Jerkeman, Mats; Gronbaek, Kirsten; Elonen, Erkki; Räty, Riikka. (2014) Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma. Blood
  Academic article

2013

• Rø, Torstein Baade; Holien, Toril; Fagerli, Unn-Merete; Hov, Håkon; Misund, Kristine; Waage, Anders. (2013) HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase. Experimental Hematology
  Academic article
• Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Fosså, Alexander; Hammerstrøm, Jens; Fagerli, Unn-Merete. (2013) High dose therapy with autologous stem cell support for lymphoma-from experimental to standard treatment. Tidsskrift for Den norske legeforening
  Academic article
• Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn-Merete; Fluge, Øystein. (2013) High dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008. Tidsskrift for Den norske legeforening
  Academic article
• Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn Merete; Fluge, Øystein. (2013) Høydosebehandling med autolog stamcellestøtte ved lymfom i Norge 1987 - 2008. Tidsskrift for Den norske legeforening
  Academic article

2012

• Arne, Kolstad; Laurell, Anna; Jerkeman, Mats; Grønbæk, Kirsten; Elonen, Erkki; Räty, Riikka. (2012) Nordic MCL3 Study: Zevalin Combined with High-Dose Chemotherapy Followed by Autologous Stem Cell Support As Late Intensification for Mantle Cell Lymphoma (MCL) Patients < 66 Years Not in CR After Induction Chemoimmunotherapy: No Benefit of Zevalin. Blood
  Abstract
• d'Amore, Francesco; Leppä, Sirpa; da Silva, Maria Gomes; Relander, Thomas; Brown, Peter de Nully; Weidmann, Eckhart. (2012) First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy. Blood
  Abstract
• d'Amore, Francesco; Relander, Thomas; Lauritzsen, Grete Fossum; Jantunen, Esa; Hagberg, Hans; Anderson, Harald. (2012) Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01. Journal of Clinical Oncology
  Academic article
• Wader, Karin Fahl; Fagerli, Unn-Merete; Børset, Magne; Lydersen, Stian; Hov, Håkon; Sundan, Anders. (2012) Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease. Histopathology
  Academic article

2011

• Fagerli, Unn-Merete; Ullrich, K; Stühmer, Thorsten; Holien, Toril; Köchert, K; Holt, Randi Utne. (2011) Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells. Oncogene
  Academic article
• Wader, Karin Fahl; Fagerli, Unn-Merete; Holt, Randi Utne; Børset, Magne; Sundan, Anders; Waage, Anders. (2011) Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parameters. European Journal of Haematology
  Academic article
• Eide, Marianne Brodtkorb; Lauritzsen, Grete Fossum; Kvalheim, Gunnar; Kolstad, Arne; Fagerli, Unn-Merete; Maisenhölder, Martin. (2011) High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. British Journal of Haematology
  Academic article

2010

• Jantunen, Esa; Relander, Thomas; Lauritzsen, Grete Fossum; Hagberg, Hans; Anderson, Harald; Cavallin-Stahl, Eva. (2010) Intensive Induction Chemotherapy Followed by Autologous. Stem Cell Transplantation (ASCT) In Patients with Enteropathy-Associated T-Cell Lymphoma: a Prospective Study by the Nordic Lymphoma Group (NLG-T-01). Blood
  Abstract
• Relander, Thomas; Lauritzsen, Grete Fossum; Jantunen, Esa; Hagberg, Hans; Anderson, Harald; Cavallin-Ståhl, Eva. (2010) Favorable Outcome In ALK-Negative Anaplastic Large-Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT): a Prospective Study by the Nordic Lymphoma Group (NLG-T-01). Blood
  Abstract
• Fagerli, Unn-Merete; Stühmer, Thorsten; Holien, Toril; Holt, Randi Utne; Bruland, Ove; Chatterjee, Manik. (2010) Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells. Blood
  Abstract

2009

• Fagerli, Unn-Merete; Sundan, Anders; Børset, Magne. (2009) Multiple myeloma cells and cytokines from the bone marrow environment; aspects of growth regulation and migration. NTNU
  Doctoral dissertation
• Kolstad, Arne; Laurell, Anna; Andersen, Niels S.; Elonen, Erkki; Räty, Riikka; Pedersen, Lone Bredo. (2009) (90)y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma.- Preliminary Results From the Third Nordic MCL Phase II Study (MCL3). Blood
  Abstract
• Holt, Randi Utne; Fagerli, Unn-Merete; Holien, Toril; Hov, Håkon; Waage, Anders; Sundan, Anders. (2009) HGF AND IGF-1 POTENTIATE SDF-1 MEDIATED MYELOMA CELL MIGRATION THROUGH ACTIVATION OF PAK. Haematologica
  Abstract
• Hov, Håkon; Tian, Erming; Holien, Toril; Holt, Randi Utne; Våtsveen, Thea; Fagerli, Unn-Merete. (2009) c-Met signaling promotes IL-6-induced myeloma cell proliferation. European Journal of Haematology
  Academic article
• Brenne, Anne-Tove; Fagerli, Unn Merete; Shaughnessy, JD; Våtsveen, Thea Kristin; Rø, Torstein Baade; Hella, Hanne. (2009) High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis. European Journal of Haematology
  Academic article
• Hov, Håkon; Tian, Erming; Holien, Toril; Holt, Randi Utne; Våtsveen, Thea Kristin; Fagerli, Unn Merete. (2009) c-Met signaling promotes IL-6-induced myeloma cell proliferation. European Journal of Haematology
  Academic article

2008

• Wader, Karin Fahl; Fagerli, Unn Merete; Holt, Randi Utne; Børset, Magne; Størdal, Berit Fladvad; Sundan, Anders. (2008) Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myeloma. European Journal of Haematology
  Academic article
• Fagerli, Unn-Merete; Holt, Randi Utne; Holien, Toril; Våtsveen, Thea Kristin; Zhan, FH; Egeberg, Kjartan Wøllo. (2008) Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells. Blood
  Academic literature review
• Holt, Randi Utne; Fagerli, Unn-Merete; Baykov, Vadim; Rø, Torstein Baade; Hov, Håkon; Waage, Anders. (2008) Hepatocyte growth factor promotes migration of human myeloma cells. Haematologica
  Academic article
• Fagerli, Unn-Merete; Holt, Randi Utne; Holien, Toril; Våtsveen, Toril; Zhan, Fenghuang; Egeberg, Kjartan. (2008) Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells. Blood
  Academic article
• Wader, Karin Fahl; Fagerli, Unn-Merete; Holt, Randi Utne; Størdal, Berit Fladvad; Børset, Magne; Sundan, Anders. (2008) Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myeloma. European Journal of Haematology
  Academic article
• Holt, Randi Utne; Fagerli, Unn-Merete; Baykov, Vadim; Rø, Torstein Baade; Hov, Håkon; Waage, Anders. (2008) Hepatocyte growth factor promotes migration of human myeloma cells. Haematologica
  Academic article

2007

• Fagerli, UM; Holt, RU; Holien, T; Vaatsveen, T; Zhan, F; Barlogie, B. (2007) PRL-3 is overexpressed in MM and involved in cell migration. Haematologica
  Abstract
• Wader, KF; Fagerli, UM; Bofin, AM; Børset, Magne; Waage, Anders. (2007) Immunohistochemical analysis of HGF in plasma cell disease. Haematologica
  Abstract
• Holt, RU; Fagerli, UM; Ro, TB; Baykov, V; Waage, Anders; Sundan, Anders. (2007) HGF promotes migration of myeloma cells. Haematologica
  Abstract
• Standal, Therese; Abildgaard, N; Fagerli, Unn-Merete; Stordal, B; Hjertner, ¯yvind; Børset, Magne. (2007) HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma. Blood
  Academic article
• Holt, Randi Utne; Fagerli, Unn-Merete; Rø, Torstein Baade; Baykov, Vadim; Waage, Anders; Sundan, Anders. (2007) HGF promotes migration of myeloma cells. Haematologica
  Abstract
• Fagerli, Unn-Merete; Holt, Randi Utne; Holien, Toril; Våtsveen, Toril; Zhan, Fenghuang; Barlogie, Bart. (2007) PRL-3 is overexpressed in MM and involved in cell migration. Haematologica
  Abstract

2006

• Baykov, Vadim; Børset, Magne; Fagerli, Unn-merete; Sundan, Anders. (2006) Пролиферация клеток миеломных клеточных линий под влиянием цитокинов и ингибиторов основных узлов внутиклеточных сигнальных каскадов "Myeloma cell lines are heterogeneous in their response to cytokines and inhibitors of intracellular signaling". Medicinskij akademiceskij žurnal (Meditsinskij Akademitsjeskij Journal)
  Academic article
• Standal, Therese; Abildgaard, Niels; Fagerli, Unn-merete; Størdal, Berit Fladvad; Hjertner, Øyvind; Børset, Magne. (2006) HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma. Blood
  Abstract
• Hov, Håkon; Fagerli, Unn-merete; Tian, Erming; Waage, Anders; Børset, Magne; Sundan, Anders. (2006) IL-6, IGF-1 and IL-21 Act in Synergy with HGF in Myeloma Cells by Inducing the HGF-Receptor c-Met. Blood
  Abstract

2004

• Hov, Håkon; Holt, Randi Utne; Rø, Torstein Baade; Fagerli, Unn-Merete; Hjort-Hansen, Henrik; Baykov, Vadim. (2004) A Selective c-Met Inhibitor Blocks an Autocrine Hepatocyte Growth Factor Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma cells. Clinical Cancer Research
  Academic article
• Hov, Håkon; Holt, Randi Utne; Rø, Torstein; Fagerli, Unn-merete; Hjorth-Hansen, Henrik; Baykov, Vadim. (2004) A selective c-Met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells. Clinical Cancer Research
  Academic article

1998

• Aarset, Harald; Fagerli, U.M; Opsjøn, S.L.; Skarsvåg, S.. (1998) A nurse with a rash on her neck. The Lancet
  Academic article
• Aarset, Harald; Fagerli, Unn-Merete; Opsjøn, S.L.; Skarsvåg, S.. (1998) A nurse with a rash on her neck. The Lancet
  Academic article